After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RNAC belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Cartesian Therapeutics Inc is $455.18M. A total of 68502.0 shares were traded on the day, compared to an average of 103.60K shares.
In the most recent transaction, Kurtoglu Metin sold 32,789 shares of RNAC for 16.67 per share on Nov 21 ’24. After the transaction, the Chief Technology Officer now owns 51,033 company shares. In a previous transaction on Nov 20 ’24, Kurtoglu Metin sold 5,700 shares at 17.29 per share. RNAC shares that Chief Technology Officer owns now total 51,033.
Among the insiders who sold shares, Kurtoglu Metin disposed of 200 shares on Nov 19 ’24 at a per-share price of $19.50. This resulted in the Chief Technology Officer holding 51,033 shares of RNAC after the transaction. In another insider transaction, METIN KURTOGLU bought 32,789 shares at $16.67 per share on Nov 21 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RNAC has a high of $42.60 and a low of $11.66.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RNAC’s latest balance sheet shows that the firm has $128.06M in Cash & Short Term Investments as of fiscal 2021. There were $35.28M in debt and $72.25M in liabilities at the time. Its Book Value Per Share was $0.03, while its Total Shareholder’s Equity was $22.52M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RNAC is Buy with a score of 4.57.
